A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

NCT07392736 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: AL8326 tablets
DRUG: Toripalimab

Sponsor

Advenchen Laboratories, LLC